zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler for systemisk bruk, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
actos 30 mg
orifarm as - pioglitazonhydroklorid - tablett - 30 mg
lipitor 10 mg
orifarm as - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg
lipitor 40 mg
orifarm as - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg
lipitor 80 mg
orifarm as - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg
somac 20 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg
somac 20 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg
somac 40 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg
trileptal 300 mg
orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg
trileptal 300 mg
orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg